Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$177.23 - $227.44 $108,464 - $139,193
-612 Reduced 33.3%
1,226 $234,000
Q2 2022

Aug 11, 2022

BUY
$181.58 - $368.0 $49,026 - $99,360
270 Added 17.22%
1,838 $339,000
Q3 2021

Nov 10, 2021

BUY
$405.61 - $524.84 $24,336 - $31,490
60 Added 3.98%
1,568 $636,000
Q2 2021

Aug 02, 2021

BUY
$372.84 - $481.5 $9,321 - $12,037
25 Added 1.69%
1,508 $714,000
Q1 2021

May 13, 2021

SELL
$361.28 - $504.76 $148,486 - $207,456
-411 Reduced 21.7%
1,483 $570,000
Q4 2020

Jan 27, 2021

SELL
$292.7 - $370.96 $14,635 - $18,548
-50 Reduced 2.57%
1,894 $701,000
Q3 2020

Nov 12, 2020

SELL
$268.51 - $400.74 $11,545 - $17,231
-43 Reduced 2.16%
1,944 $601,000
Q2 2020

Jul 17, 2020

SELL
$256.46 - $373.01 $7,950 - $11,563
-31 Reduced 1.54%
1,987 $736,000
Q1 2020

Apr 23, 2020

SELL
$209.2 - $335.53 $10,460 - $16,776
-50 Reduced 2.42%
2,018 $551,000
Q4 2019

Jan 10, 2020

SELL
$288.29 - $335.49 $64,865 - $75,485
-225 Reduced 9.81%
2,068 $686,000
Q3 2019

Oct 08, 2019

SELL
$266.84 - $378.23 $20,012 - $28,367
-75 Reduced 3.17%
2,293 $698,000
Q2 2019

Jul 10, 2019

SELL
$300.59 - $368.15 $60,117 - $73,630
-200 Reduced 7.79%
2,368 $872,000
Q1 2019

Apr 09, 2019

SELL
$272.57 - $321.18 $298,464 - $351,692
-1,095 Reduced 29.89%
2,568 $798,000
Q4 2018

Jan 16, 2019

SELL
$272.46 - $366.54 $26,973 - $36,287
-99 Reduced 2.63%
3,663 $1.1 Million
Q3 2018

Oct 12, 2018

SELL
$279.04 - $367.06 $144,542 - $190,137
-518 Reduced 12.1%
3,762 $1.38 Million
Q2 2018

Jul 24, 2018

SELL
$228.17 - $292.07 $28,521 - $36,508
-125 Reduced 2.84%
4,280 $1.2 Million
Q1 2018

May 08, 2018

BUY
$209.54 - $253.91 $5,867 - $7,109
28 Added 0.64%
4,405 $1.04 Million
Q4 2017

Feb 13, 2018

SELL
$202.23 - $230.03 $16,785 - $19,092
-83 Reduced 1.86%
4,377 $956,000
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $768,458 - $954,127
4,460
4,460 $0

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Douglass Winthrop Advisors, LLC Portfolio

Follow Douglass Winthrop Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.